Literature DB >> 25001623

ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.

Kyung-Sun Heo1, Hannah J Cushman2, Masashi Akaike2, Chang-Hoon Woo2, Xin Wang2, Xing Qiu2, Keigi Fujiwara2, Jun-ichi Abe1.   

Abstract

BACKGROUND: Efferocytosis is a process by which dead and dying cells are removed by phagocytic cells. Efferocytosis by macrophages is thought to curb the progression of atherosclerosis, but the mechanistic insight of this process is lacking. METHODS AND
RESULTS: When macrophages were fed apoptotic cells or treated with pitavastatin in vitro, efferocytosis-related signaling and phagocytic capacity were upregulated in an ERK5 activity-dependent manner. Macrophages isolated from macrophage-specific ERK5-null mice exhibited reduced efferocytosis and levels of gene and protein expression of efferocytosis-related molecules. When these mice were crossed with low-density lipoprotein receptor(-/-) mice and fed a high-cholesterol diet, atherosclerotic plaque formation was accelerated, and the plaques had more advanced and vulnerable morphology.
CONCLUSIONS: Our results demonstrate that ERK5, which is robustly activated by statins, is a hub molecule that upregulates macrophage efferocytosis, thereby suppressing atherosclerotic plaque formation. Molecules that upregulate ERK5 and its signaling in macrophages may be good drug targets for suppressing cardiovascular diseases.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; signal transduction

Mesh:

Substances:

Year:  2014        PMID: 25001623      PMCID: PMC4439099          DOI: 10.1161/CIRCULATIONAHA.113.005991

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

Review 1.  Clearance of apoptotic cells: getting rid of the corpses.

Authors:  Kirsten Lauber; Sibylle G Blumenthal; Michaela Waibel; Sebastian Wesselborg
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

2.  Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway.

Authors:  Takafumi Senokuchi; Takeshi Matsumura; Masakazu Sakai; Miyuki Yano; Tetsuya Taguchi; Tomoko Matsuo; Kazuhiro Sonoda; Daisuke Kukidome; Koujiroh Imoto; Takeshi Nishikawa; Shokei Kim-Mitsuyama; Yoh Takuwa; Eiichi Araki
Journal:  J Biol Chem       Date:  2004-12-17       Impact factor: 5.157

3.  ICER induced by hyperglycemia represses the expression of genes essential for insulin exocytosis.

Authors:  Amar Abderrahmani; Séverine Cheviet; Mourad Ferdaoussi; Thierry Coppola; Gérard Waeber; Romano Regazzi
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

Review 4.  PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

Authors:  B M Spiegelman
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

5.  Late effects of TNF-alpha-induced inflammation on the microcirculation of cremaster muscle flaps under intravital microscopy.

Authors:  Kagan Ozer; Gokhan Adanali; Maria Siemionow
Journal:  J Reconstr Microsurg       Date:  2002-01       Impact factor: 2.873

6.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

7.  The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency.

Authors:  Christian Lytle; Tara J Tod; Kathy T Vo; Jimmy W Lee; Roscoe D Atkinson; Daniel S Straus
Journal:  Inflamm Bowel Dis       Date:  2005-03       Impact factor: 5.325

8.  Opsonin receptor expression on peritoneal exudative and circulatory neutrophils in murine acute pancreatitis.

Authors:  N Hatano; M Sugiyama; T Watanabe; Y Atomi
Journal:  Pancreas       Date:  2001-07       Impact factor: 3.327

Review 9.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

Review 10.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

View more
  27 in total

1.  sNASP inhibits TLR signaling to regulate immune response in sepsis.

Authors:  Feng-Ming Yang; Yong Zuo; Wei Zhou; Chuan Xia; Bumsuk Hahm; Mark Sullivan; Jinke Cheng; Hui-Ming Chang; Edward Th Yeh
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

Review 2.  The Role of Inflammation in Cardiovascular Outcome.

Authors:  Fabrizio Montecucco; Luca Liberale; Aldo Bonaventura; Alessandra Vecchiè; Franco Dallegri; Federico Carbone
Journal:  Curr Atheroscler Rep       Date:  2017-03       Impact factor: 5.113

3.  Senescent Phenotype Induced by p90RSK-NRF2 Signaling Sensitizes Monocytes and Macrophages to Oxidative Stress in HIV-Positive Individuals.

Authors:  Meera V Singh; Sivareddy Kotla; Nhat-Tu Le; Kyung Ae Ko; Kyung-Sun Heo; Yin Wang; Yuka Fujii; Hang Thi Vu; Elena McBeath; Tamlyn N Thomas; Young Jin Gi; Yunting Tao; Jan L Medina; Jack Taunton; Nancy Carson; Vikram Dogra; Marvin M Doyley; Alicia Tyrell; Wang Lu; Xing Qiu; Nicole E Stirpe; Kathleen J Gates; Christine Hurley; Keigi Fujiwara; Sanjay B Maggirwar; Giovanni Schifitto; Jun-Ichi Abe
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

4.  Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.

Authors:  Zhu-Xia Shen; Xiao-Qing Chen; Xue-Nan Sun; Jian-Yong Sun; Wu-Chang Zhang; Xiao-Jun Zheng; Yu-Yao Zhang; Huan-Jing Shi; Jia-Wei Zhang; Chao Li; Jun Wang; Xu Liu; Sheng-Zhong Duan
Journal:  J Biol Chem       Date:  2016-11-23       Impact factor: 5.157

5.  Rubiarbonone C inhibits platelet-derived growth factor-induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr705 signalling pathways.

Authors:  Hyun-Soo Park; Khong Trong Quan; Joo-Hui Han; Sang-Hyuk Jung; Do-Hyung Lee; Eunji Jo; Tae-Wan Lim; Kyung-Sun Heo; MinKyun Na; Chang-Seon Myung
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

Review 6.  The walking dead: macrophage inflammation and death in atherosclerosis.

Authors:  Mary M Kavurma; Katey J Rayner; Denuja Karunakaran
Journal:  Curr Opin Lipidol       Date:  2017-04       Impact factor: 4.776

Review 7.  Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.

Authors:  MacRae F Linton; Vladimir R Babaev; Jiansheng Huang; Edward F Linton; Huan Tao; Patricia G Yancey
Journal:  Circ J       Date:  2016-10-08       Impact factor: 2.993

8.  Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4.

Authors:  Feng-Ming Yang; Hui-Ming Chang; Edward T H Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

9.  MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.

Authors:  Bishuang Cai; Edward B Thorp; Amanda C Doran; Manikandan Subramanian; Brian E Sansbury; Chyuan-Sheng Lin; Matthew Spite; Gabrielle Fredman; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-19       Impact factor: 11.205

10.  ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.

Authors:  M Yang; J Liu; C Piao; J Shao; J Du
Journal:  Cell Death Dis       Date:  2015-06-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.